Liquidia Corp. (LQDA)
68.15
+0.46
(+0.68%)
USD |
NASDAQ |
Aug 31, 16:00
68.26
+0.11
(+0.16%)
After-Hours: 19:44
Liquidia Cash from Operations (Annual) : -35.69M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -35.69M |
| December 31, 2024 | -93.42M |
| December 31, 2023 | -41.56M |
| December 31, 2022 | -28.59M |
| December 31, 2021 | -34.04M |
| Date | Value |
|---|---|
| December 31, 2020 | -54.14M |
| December 31, 2019 | -48.28M |
| December 31, 2018 | -31.83M |
| December 31, 2017 | -24.29M |
| December 31, 2016 | -13.95M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Indivior Pharmaceuticals, Inc. | -27.00M |
| Harmony Biosciences Holdings, Inc. | 348.20M |
| Johnson & Johnson | 24.53B |
| United Therapeutics Corp. | 1.561B |
| Amneal Pharmaceuticals, Inc. | 339.99M |